This perspective paper proposes a reframing of obesity-related type 2 diabetes (T2D) and prediabetes: rather than treating insulin resistance and impaired insulin secretion as pure pathology, the authors argue these represent coordinated allostatic responses to chronic nutrient excess aimed at reducing metabolic stress in vulnerable tissues.
The authors propose that insulin resistance, attenuated glucose-stimulated insulin secretion, modest hyperglycemia, and glucosuria may each serve a protective role by limiting glucose flux into metabolically stressed tissues — reframing T2D not as a failure of glucose regulation but as an adaptive system response to chronic energy surplus.
This is a theoretical/conceptual paper without primary data, so the allostatic framework is not directly tested. The model's clinical implications rely heavily on reinterpreting existing evidence rather than new empirical findings.
When choosing therapies for early T2D, consider not just how well they lower glucose but *how* they alter tissue-specific glucose handling and metabolic stress — interventions that address underlying nutrient excess (e.g., weight loss, GLP-1 receptor agonists) may outperform those that simply restore insulin action or secretion.
Explore related topics
